# Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

> clinical trial · VERIFIED · 2026-08-07

Status: ACTIVE_NOT_RECRUITING · Sponsor: ITM Solucin GmbH · Condition: Neuroendocrine Tumors

- Company: ITM Solucin GmbH
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03049189

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.